Phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer
2008 ◽
Vol 26
(15_suppl)
◽
pp. 1075-1075
◽
Keyword(s):
Phase Ii
◽
2012 ◽